We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · March 04, 2021

Efficacy of Lasmiditan Across Four Migraine Attacks

Cephalalgia: An International Journal of Headache


Additional Info

Disclosure statements are available on the authors' profiles:

Cephalalgia: An International Journal of Headache
Randomized, Controlled Trial of Lasmiditan Over Four Migraine Attacks: Findings From the CENTURION Study
Cephalalgia 2021 Feb 04;[EPub Ahead of Print], M Ashina, U Reuter, T Smith, J Krikke-Workel, SR Klise, S Bragg, EG Doty, SA Dowsett, Q Lin, JH Krege

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading